国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
12期
1566-1567,1570
,共3页
蒙秀坚%陈秀勤%陆爱英%欧宁江%汤敏中
矇秀堅%陳秀勤%陸愛英%歐寧江%湯敏中
몽수견%진수근%륙애영%구저강%탕민중
肿瘤标志物%糖类抗原19-9%血清
腫瘤標誌物%糖類抗原19-9%血清
종류표지물%당류항원19-9%혈청
serum tumor marker%CA1 9-9%serum
目的:探讨血清肿瘤标志物糖类抗原19-9(CA19-9)在不同类型肿瘤患者及健康人血清中的检测水平,系统性地评价其在肿瘤中的临床应用价值。方法采用化学发光免疫蛋白定量分析法对767例肿瘤患者(病例组)及288例同期健康体检个体(对照组)进行血清CA19-9检测。结果在对照组中,CA19-9普遍具有较低的表达水平,均值为(14.2±8.9)IU/mL,但是在不同系统的恶性肿瘤中均发现血清CA19-9水平显著上升,在同一系统不同类型的恶性肿瘤当中,血清CA19-9水平也各有差异,呈现出表达水平的异质性。结论 CA19-9在食管癌、肝癌、胰腺癌、胆囊癌等恶性肿瘤中呈高水平表达,提示 CA19-9在临床检测中具有较高的应用价值,但其在一些良性肿瘤和炎症病变中的高表达也提示临床在CA19-9的应用中仍需注意对相关良性肿瘤的鉴别分析。
目的:探討血清腫瘤標誌物糖類抗原19-9(CA19-9)在不同類型腫瘤患者及健康人血清中的檢測水平,繫統性地評價其在腫瘤中的臨床應用價值。方法採用化學髮光免疫蛋白定量分析法對767例腫瘤患者(病例組)及288例同期健康體檢箇體(對照組)進行血清CA19-9檢測。結果在對照組中,CA19-9普遍具有較低的錶達水平,均值為(14.2±8.9)IU/mL,但是在不同繫統的噁性腫瘤中均髮現血清CA19-9水平顯著上升,在同一繫統不同類型的噁性腫瘤噹中,血清CA19-9水平也各有差異,呈現齣錶達水平的異質性。結論 CA19-9在食管癌、肝癌、胰腺癌、膽囊癌等噁性腫瘤中呈高水平錶達,提示 CA19-9在臨床檢測中具有較高的應用價值,但其在一些良性腫瘤和炎癥病變中的高錶達也提示臨床在CA19-9的應用中仍需註意對相關良性腫瘤的鑒彆分析。
목적:탐토혈청종류표지물당류항원19-9(CA19-9)재불동류형종류환자급건강인혈청중적검측수평,계통성지평개기재종류중적림상응용개치。방법채용화학발광면역단백정량분석법대767례종류환자(병례조)급288례동기건강체검개체(대조조)진행혈청CA19-9검측。결과재대조조중,CA19-9보편구유교저적표체수평,균치위(14.2±8.9)IU/mL,단시재불동계통적악성종류중균발현혈청CA19-9수평현저상승,재동일계통불동류형적악성종류당중,혈청CA19-9수평야각유차이,정현출표체수평적이질성。결론 CA19-9재식관암、간암、이선암、담낭암등악성종류중정고수평표체,제시 CA19-9재림상검측중구유교고적응용개치,단기재일사량성종류화염증병변중적고표체야제시림상재CA19-9적응용중잉수주의대상관량성종류적감별분석。
Objective To evaluate the clinical application value of carbohydrate antigen 1 9-9 (CA1 9-9 )in different kinds of tumors.Methods Serum levels of CA19-9 were detected in 767 tumor or benign tumor patients (case group)and 288 health sub-jects (control group)by using chemoluminescence assay.Results Serum level of CA19-9 in control group was (14.2±8.9)IU/mL,which was significantly lower than case group.Serum levels of CA19-9 were with differences in patients with cancers of differ-ent systems,and those in patients with different types of cancers of the same system were also with differences,indicating that ser-um CA19-9 expression levels could be heterogeneous in cancer patients.Conclusion High serum expression levels of CA19-9 could be detected in patients with esophageal carcinoma,liver cancer,pancreatic cancer,or gallbladder carcinoma and so on,indicating that CA1 9-9 might be with important clinical value.But high expression levels of serum CA1 9-9 in some benign tumors might indicate that more attention should be paid for the differential diagnosis of benign tumors in clinical application.